Home›Companies›Biotech & Pharma›Myosin Therapeutics

Myosin Therapeutics Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 24, 2023·Suggest an edit

About Myosin Therapeutics

Myosin Therapeutics is a private company based in Jupiter, Florida, incorporated in 2020 in Delaware. It has reported $2,999,986 raised in one offering on Form D since December 2022.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 2, 2022Dec 19, 2022amended Mar 24, 2023$2,999,986fully sold4$749KEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Myosin Therapeutics's Form D filed Mar 24, 2023.

DA
Dave Adams
Director
AR
CM
Courtney Miller
President and director
RF
Robert Finizio
Director
Also an executive director at PleoPharma.

Sources

  1. SECMyosin Therapeutics Inc. Form D, filed Dec 19, 2022
  2. SECMyosin Therapeutics Inc. filing history